Skip to main content
NewslettersWatchlist

Regulus Therapeutics(RGLS-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Regulus Therapeutics Strengthens Research & Development Leadership

PR Newswire - Mon Jun 12, 2023

Appoints Preston S. Klassen, M.D., as President and Head of Research & Development

Curtis A. Monnig, Ph.D., named Vice President of CMC

SAN DIEGO, June 12, 2023 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced the appointment of Preston S. Klassen M.D., M.H.S., to President and Head of Research and Development. Dr. Klassen brings over 20 years of experience in leadership roles in both large and small biopharmaceutical companies. In addition, the Company announced the appointment of Curtis A. Monnig, Ph.D., to Vice President of CMC. 

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

market news
At midday: North American stock markets rise on early rate-cut hopes
A trader works inside a booth on the floor of the New York Stock Exchange on May 1.
market news
The close: Major North American indexes higher, led by Nasdaq, amid plethora of mixed earnings
Traders work on the floor at the New York Stock Exchange in New York, Wednesday, May 1.
international business
Trump awarded 36 million more Trump Media shares worth $1.8-billion after hitting price benchmarks
Former President Donald Trump speaks to reporters as he leaves the courtroom for the day at Manhattan criminal court, in New York, U.S., April 30, 2024. Seth Wenig/Pool via REUTERS
investor newsletter
The key to successful investing. Plus, why Fairfax Financial is poised for an extraordinary run
investor happy money
market news
The close: Stocks mixed as Fed leaves investors guessing as to when rate cuts will arrive
NEW YORK, NEW YORK - APRIL 29: Traders work on the floor of the New York Stock Exchange during morning trading on April 29, 2024 in New York City. Stocks opened high Monday morning amid a Federal Reserve rate decision and the monthly jobs report later this week. (Photo by Michael M. Santiago/Getty Images)
inside the market
Tuesday’s analyst upgrades and downgrades
Samuel Drouin-Tardif, an electro-mechanic for Boralex, walks in the snow while looking at a wind turbine in Thetford Mines November 24, 2023.
market news
The close: Major indexes fall after wage data; cannabis shares surge on U.S. regulatory move
The Art Deco facade of the original Toronto Stock Exchange building is seen on Bay Street in Toronto in January of 2019.
market news
The close: Stocks higher as investors focus on Fed moves
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., April 26.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).